Antifibrinolytic Agents
- Name
- Antifibrinolytic Agents
- Accession Number
- DBCAT000387
- Description
Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders.
- ATC Classification
- Drugs
Drug Drug Description Tranexamic acid An antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. Aminocaproic acid An antifibrinolytic agent used to induce clotting postoperatively. Aprotinin A serine protease inhibitor used to reduce the risk for perioperative blood loss and the need for blood transfusion in high-risk patients during cardiopulmonary bypass for coronary artery bypass graft surgery. Menadione The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification. Alpha-1-proteinase inhibitor A purified form of human alpha-1 proteinase inhibitor used to treat emphysema patients with associated alpha-1 proteinase inhibitor deficiency. Aminomethylbenzoic acid Aminomethylbenzoic acid may be useful as an antifibrinolytic agent . Camostat A serine protease indicated in Japan to treat chronic pancreatitis. Hydrogen peroxide A compound used as a disinfectant and sterilizer. Ulinastatin Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug. Menadione bisulfite Not Annotated - Drugs & Drug Targets